Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00059735 · ClinicalTrials.gov registry record · Phase 2

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

A Phase 2 study, sponsored by Eisai.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target

NCT00059735: Completed Phase 2 study, sponsored by Eisai.

NCT00059735 is a Phase 2 study that has completed, run by Eisai. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00059735, a Phase 2 study, has completed, sponsored by Eisai.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.

Interventions

  • DRUG E7070

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2002-05
Est. Completion 2003-12
Phase Phase 2
Eisai

287 total trials

What the finished NCT00059735 record still lists

NCT00059735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 1 intervention - of which E7070 is the first listed.

NCT00059735 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00059735 about?

NCT00059735 is a clinical study titled "A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma". The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.

What is the current status of trial NCT00059735?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2002-05. Estimated completion is 2003-12.

What interventions are being tested in trial NCT00059735?

The interventions under investigation include: E7070 (DRUG).

Who is sponsoring clinical trial NCT00059735?

This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00059735's enrollment target sits among peer trials

30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00059735, the US trial registry maintained by the National Library of Medicine. NCT00059735 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.